1. Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma
    Nekisa Zakeri et al, 2022, Nature Communications CrossRef
  2. γδ T cells in hepatocellular carcinoma patients present cytotoxic activity but are reduced in potency due to IL-2 and IL-21 pathways
    Hang Jiang et al, 2019, International Immunopharmacology CrossRef
  3. Biological characteristics of γδT cells and application in tumor immunotherapy
    Renhong Zhu et al, 2023, Frontiers in Genetics CrossRef
  4. Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection
    Wen Hou et al, 2021, Frontiers in Immunology CrossRef
  5. γδ T cells in liver diseases
    Xuefu Wang et al, 2018, Frontiers of Medicine CrossRef
  6. Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells
    Camille Khairallah et al, 2018, Frontiers in Immunology CrossRef
  7. Persistent gamma delta T‐cell dysfunction in chronic HCV infection despite direct‐acting antiviral therapy induced cure
    Alip Ghosh et al, 2019, Journal of Viral Hepatitis CrossRef
  8. γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
    Stavros P. Papadakos et al, 2024, International Journal of Molecular Sciences CrossRef
  9. Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor
    Rishu Takimoto et al, 2020, Cytotherapy CrossRef
  10. Obesity linking to hepatocellular carcinoma: A global view
    Lu Gan et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  11. The potential of adoptive transfer of γ9δ2 T cells to enhance blinatumomab’s antitumor activity against B-cell malignancy
    Yun-Hsiang Chen et al, 2021, Scientific Reports CrossRef
  12. In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity
    Yongting Liu et al, 2021, Cell & Bioscience CrossRef
  13. CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial
    Anne Gomez-Brouchet et al, 2017, OncoImmunology CrossRef